Tirzepatide may take it a step further, leveraging combined GIP and GLP-1 actions to curb appetite, boost energy expenditure, and drive greater weight loss
[Study 906] Heymsfield SB, Aronne LJ, Montgomery P, Klickstein LB, Coleman LA, Dole K, et al
Legitimate vendors clearly label their products as "for research use only" and do not make therapeutic claims
Oral semaglutide typically starts at 3 mg daily for 30 days, then increases to 7 mg daily, with optional escalation to 14 mg if additional glycemic control is needed
GLP-1 Maintenance Is Not One Decision Patients often ask, Do I have to stay on GLP-1 medication forever? The better answer is that maintenance is not one decision